IMNM compared with STTK: revenue, margins and what each company keeps, and the suppliers and customers both name

IMNMImmunome Inc.

Mkt capRevenueRevenue

STTKShattuck Labs, Inc.

Mkt capRevenueRevenue

Compare

IMNMImmunome Inc.

STTKShattuck Labs, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

IMNM: latest quarter is a loss; flow not drawable. STTK: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

IMNM, solidSTTK, dashed

IMNMImmunome Inc.

18.23▼−0.33%· post 18.23

Mkt cap$2.1BRevenue$4MQ2 FY25Revenue$9MFY24

STTKShattuck Labs, Inc.

5.54▼−3.18%· post 5.54

ClosedOct 30 '26

Mkt cap$558.0MRevenue$1MQ3 FY25Revenue—

Compare

ClosedOct 30 '26

IMNMImmunome Inc.

STTKShattuck Labs, Inc.

18.23▼−0.33%post 18.23

Price

5.54▼−3.18%post 5.54

$2.1B

Mkt cap

$558.0M

Q2 FY25$4M

Revenue

$1MQ3 FY25

FY24$9M

Revenue

—

IMNM18.23▼−0.33%vsSTTK5.54▼−3.18%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IMNM 5

ABBVAbbVie Global Enterprisescustomer

BMYBristol-Myers Squibbsupplier

ZNTLZentalis Pharmaceuticalssupplier

—Ayala Pharmaceuticalsunlistedsupplier

1 more · IMNM chain ›

Shared 0

No shared counterparties.

Only STTK 4

—Kemwell Biopharma Privateunlistedsupplier

—ImmunoGenunlistedcustomer

—Kayak Therapeuticsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Ono Pharmaceuticalunlistedcustomer